This finding is consistent with similar results demonstrated in various tumor studies [38, 65, 68], suggesting that different NKG2DLs expression profiles in different cell contexts do not necessarily dictate the responsiveness of NKG2D-CAR T cells. The gene discussed is KLRK1; the disease is neoplasm.